Fulgent Genetics, Inc.
Fulgent Genetics, Inc. (FLGT) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
flgt · stock forecast · 9 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 9 Wall Street analysts in the past 3 months
Buy
9 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$15.00
Consensus
$15.00
-18.1% upside
Low
$15.00
Median: $15 · Last Close: $18.31
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $19.23 | ↑ 5.00% |
1-day model range: $19.11–$19.34. Peak: $19.34 (+5.00%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $12 | -33.1% |
| 2028 | $10 | -45.3% |
| 2029 | $9 | -50.8% |
| 2030 | $9 | -53.5% |
| 2031 | — | -54.9% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · FLGT · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-05 | Piper Sandler | Maintains | Neutral→Neutral |
| 2025-11-11 | Piper Sandler | Maintains | Neutral→Neutral |
| 2025-08-05 | UBS | Upgrade ↑ | Neutral→Buy |
| 2025-08-04 | Piper Sandler | Maintains | Neutral→Neutral |
| 2025-05-06 | Piper Sandler | Maintains | Neutral→Neutral |
| 2025-05-05 | Raymond James | Maintains | Outperform→Outperform |
| 2025-03-04 | Piper Sandler | Maintains | Neutral→Neutral |
| 2024-11-11 | Piper Sandler | Maintains | Neutral→Neutral |
| 2024-03-06 | Piper Sandler | Maintains | Neutral→Neutral |
| 2023-10-16 | Piper Sandler | Maintains | Neutral→Neutral |
Wall Street analysts have recently issued updated ratings on Fulgent Genetics, Inc. (FLGT) stock. Of the recent 40 rating actions, 3 were upgrades and 6 were downgrades. 9 analysts currently cover FLGT.
Analyst Recommendation Trends
FLGT analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 0 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$282M
↓ 19.9% YoY
Revenue Next Year
$325M
↑ 15.1% YoY
EPS This Year
$0.33
EPS Next Year
$0.28
↓ 14.0% YoY
EPS ForecastReported vs Estimated
Analysts forecast FLGT EPS of $0.33 for the current fiscal year, based on estimates from 2 analysts. The FLGT revenue forecast is $282M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The FLGT stock forecast is supported by two independent data sources: analyst consensus ratings from 9 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus FLGT price target is $15.00 (-18.1% upside), with an analyst consensus of Buy.
The FLGT short-term stock prediction for tomorrow is $19.23 (+5.00%). The FLGT stock price prediction for 2027 estimates an average of $12. The FLGT stock prediction for 2030 projects a range of $8–$9.
Fulgent Genetics, Inc. trades on NASDAQ under the ticker FLGT. The FLGT stock outlook for 2027 is broadly positive, supported by a Buy consensus among 67% of covering analysts.
Frequently asked questions
FLGT forecast · 8 questionsAccording to 9 Wall Street analysts, the average 12-month FLGT price target is $15.00, with a high forecast of $15.00 and a low of $15.00. The median price target is shown in the chart above when available. This implies -18.1% potential upside from the current price of $18.31.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.